MIRA
INFORM REPORT
|
Report Date : |
05.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
ZOETIS PHARMACEUTICAL RESEARCH PRIVATE LIMITED (w.e.f. 19.04.2013) |
|
|
|
|
Formerly Known
As : |
PFIZER
PHARMACEUTICAL INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Pfizer Centre, 5 Patel Estate, Off. |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
02.01.1995 |
|
|
|
|
Com. Reg. No.: |
11-084206 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 5077.320 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24117MH1995FTC084206 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AADCP5293L |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Trading in Bulk Drugs, Formulations and Empty Vegetable Capsules. |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (54) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 52000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having good track record. Fundamentals of the company is decent. Financial position of the company
is strong and healthy. Trade relation reported to be fair. Business is active. Payment terms
are reported to be regular and as per commitment. The company can be considered normal for business dealing at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
As per the latest IMF study, the total weigh of emerging markets in the
GDP of the world on a purchasing power parity basis has seen a sizeable shift.
It highlights how as against 51 % in 2005, the emerging economies now account
for close to 56 % of the global purchasing power GDP as per the latest survey.
And with the emerging economies growing at a faster rate than their developed
counterparts, there are every possibility that the their share goes up further
in the coming years. China may surpass the US over the next few years.
Politics and economics are very intricately connected. They tend to
influence each other in ways that could be very complex and far-reaching. The
prospects of the India’s economy have been seriously compromised due to
political corruption. High inflation, poor standard of living are to a great
extent a result of rampant corruption in the country. China on the other hand,
seems to be facing diametrically opposite challenge. American hedge fund manager
Jim Chanos has been keenly following the political and economic development in
the dragon economy and has figured out something that is quite worrying. He is
of the view that the Chinese economy could be heading toward trouble on account
of new Chinese President Xi Jingping’s very aggressive anti-corruption drive.
Chanos believes tat many things such as apartment sales, luxury products, etc.
were largely bought with dirty money. And it is now beginning to impact
consumption. This may indeed be bad news for an economy that is struggling to
transition from an investment-driven export-oriented economy to a domestic
consumption-driven economy.
A study published by Firstpost has revealed that asset classes like real
estate and equities were the biggest beneficiaries of the liberalization
policies. A firm called Ciane Analytics studied returns from assets
including equities, gold, fixed deposits, G-Secs and real estate since 1991.
Real estate outperformed every other asset classes during the 23-year period with
an annualized return of 20 % ! Equities came in second with annualized return
of 15.5 % ! However, while these returns may seem mouthwatering, the fact is
that the return from equities adjusted for inflation came down to just 7.1 %.
Some brief news are as under
. R-Power to buy Jaypee’s hydro assets
. Investors await justice in NSEL case
. India seeks MFN status from Pakistan ahead of meeting
. Ukrain’s clashes with rebels hinder MH17 crash investigation
. India exploring merger of state-owned hydro PSUs
..Higher costs weigh down profit growth to slowest in 9 quarters
..Wal-Mart to expand wholesale business in India
. GMR group moves to strengthen balance sheet
. Central Bank to sell 4 % stake to Life Insurance Corporation
. Tata Chemicals plans to raise up to Rs 10000 mn.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DENIED BY
|
Name : |
Ms. Jaina Doshi |
|
Designation : |
Legal Manager |
|
Contact No.: |
91-22-66513800 |
|
Date : |
31.07.2014 |
LOCATIONS
|
Registered Office : |
Pfizer Centre, 5 Patel Estate, Off. S. V. Road, Jogeshwari (West),
Mumbai – 400102, Maharashtra, India |
|
Tel. No.: |
91-22-66513800 / 26574000 / 66932000 |
|
Fax No.: |
91-22-26784569 |
|
E-Mail : |
DIRECTORS
As on: 30.09.2013
|
Name : |
Mr. Joydeep Krishna Kant |
|
Designation : |
Director |
|
Address : |
Flat No. 7/8, Shimira, 16th Road, Near Khar Gymkhana, Khar
(West), Mumbai – 400052, Maharashtra, India |
|
Date of Birth/Age : |
10.01.1957 |
|
Date of Appointment : |
01.09.2007 |
|
DIN No.: |
01818820 |
|
|
|
|
Name : |
Mrs. Kavita Kirankumar Bhavnani |
|
Designation : |
Director |
|
Address : |
D-78, Premanagar, Kopri Colony Thane (East), Thane – 400603,
Maharashtra, India |
|
Date of Birth/Age : |
03.12.1971 |
|
Date of Appointment : |
24.11.2012 |
|
PAN No.: |
AEPPB3168D |
|
DIN No.: |
01918076 |
|
|
|
|
Name : |
Mr. Khursheed Kaiyomarz Marfatia |
|
Designation : |
Director |
|
Address : |
4, Ratan Mansion, 3rd Floor, Forjett Street, Mumbai –
400036, Maharashtra, India |
|
Date of Birth/Age : |
07.06.1958 |
|
Date of Appointment : |
23.11.2012 |
|
DIN No.: |
06432341 |
KEY EXECUTIVES
|
Name : |
Mr. Jaina Mahesh Doshi |
|
Designation : |
Secretary |
|
Address : |
H/602, Krishna Garden, Viva Vrindavan Towns Hip, Opposite New Viva
Collage Virar (West), Thane – 401303, Maharashtra, India |
|
Date of Birth/Age : |
09.12.1983 |
|
Date of Appointment : |
31.05.2013 |
|
PAN No.: |
AJPPD4020P |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on: 30.09.2013
|
Names of Shareholders |
|
No. of Shares |
|
Pah India Holding I.B.V. |
|
507731990 |
|
Pah India Hold Company LLC |
|
20 |
|
|
|
|
|
Total |
|
507732010 |
Equity Share Break up (Percentage of Total Equity)
As on: 30.09.2013
|
Category |
|
Percentage |
|
|
|
|
|
Bodies corporate |
|
100.00 |
|
|
|
|
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Trading in Bulk Drugs, Formulations and Empty Vegetable
Capsules. |
GENERAL INFORMATION
|
No. of Employees : |
Not Divulged |
|
|
|
|
Bankers : |
· ANZ Grindlays Bank Limited, 90; M. G. Road, Fort, Mumbai, Maharashtra, India ·
The Hongkong and Shangai Bank Company Limited,
52/60 ; Gandhi Marg, Fort, Bombay, Maharashtra, India |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
B S R and Company Chartered Accountants |
|
Address : |
Lodha Excelus, 1St Floor, Appollo Mills
Compound, N. M. Joshi Marg, Mahalakshmi, Mumbai, Maharashtra, India |
|
PAN No.: |
AAAFB9852F |
|
|
|
|
Holding company: |
· PAH India Holding B.V. |
|
|
|
|
Ultimate Holding company: |
· Pfizer Inc., USA |
|
|
|
|
Joint venture: |
· Warner–Lambert Company LLC, USA |
|
|
|
|
Fellow Subsidiary
company: |
· Pfizer Limited · Wyeth Limited · Pfizer Products India Private Limited · Pfizer S. A. de C. V., Mexico · Pfizer Ireland Pharmaceuticals, Ireland · Wyeth-Ayerst International Inc., USA · Pfizer HK Service Company Limited, Hong Kong · Wyeth Pharmaceuticals Inc., USA · Pfizer Health Solutions Inc., USA · Pfizer International LLC, USA · Pfizer Limited, UK · Wyeth Pharmaceuticals India Private Limited · PAH Singapore PTE Limited |
|
|
|
|
Subsidiary company: |
· Cap Suge L Healthcare Limited · Zoetis India Limited |
CAPITAL STRUCTURE
As on: 30.09.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
700000000 |
Equity Shares |
Rs.10/- each |
Rs. 7000.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
507732010 |
Equity Shares |
Rs.10/- each |
Rs. 5077.320
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
5077.320 |
2510.131 |
2510.131 |
|
(b) Reserves & Surplus |
8111.340 |
2835.813 |
2508.981 |
|
(c) Money received
against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total Shareholders’ Funds (1) + (2) |
13188.660 |
5345.944 |
5019.112 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term
borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
58.427 |
18.799 |
27.048 |
|
(c) Other long
term liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
8.917 |
27.341 |
29.366 |
|
Total Non-current
Liabilities (3) |
67.344 |
46.140 |
56.414 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
0.000 |
838.568 |
2865.000 |
|
(b)
Trade payables |
48.331 |
28.272 |
49.501 |
|
(c)
Other current liabilities |
128.984 |
134.045 |
243.852 |
|
(d) Short-term
provisions |
6.493 |
31.251 |
25.589 |
|
Total Current
Liabilities (4) |
183.808 |
1032.136 |
3183.942 |
|
|
|
|
|
|
TOTAL |
13439.812 |
6424.220 |
8259.468 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a)
Fixed Assets |
|
|
|
|
(i)
Tangible assets |
1419.132 |
1535.119 |
1651.535 |
|
(ii) Intangible
Assets |
0.000 |
0.000 |
0.000 |
|
(iii)
Capital work-in-progress |
17.650 |
7.495 |
8.224 |
|
(iv) Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current
Investments |
7355.644 |
2622.644 |
4176.912 |
|
(c) Deferred tax assets
(net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
264.285 |
298.437 |
234.905 |
|
(e) Other
Non-current assets |
0.000 |
0.850 |
0.000 |
|
Total Non-Current
Assets |
9056.711 |
4464.545 |
6071.576 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
0.000 |
21.019 |
0.347 |
|
(c)
Trade receivables |
442.762 |
377.449 |
239.158 |
|
(d) Cash
and cash equivalents |
1401.231 |
30.464 |
306.388 |
|
(e) Short-term
loans and advances |
2237.325 |
1433.197 |
1567.743 |
|
(f)
Other current assets |
301.783 |
97.546 |
74.256 |
|
Total
Current Assets |
4383.101 |
1959.675 |
2187.892 |
|
|
|
|
|
|
TOTAL |
13439.812 |
6424.220 |
8259.468 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
1578.397 |
1337.782 |
1299.021 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
TOTAL |
1221.971 |
1185.610 |
1312.038 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
356.426 |
152.172 |
(13.017) |
|
|
|
|
|
|
|
|
|
Less/ Add |
EXCEPTIONAL
ITEMS |
0.000 |
(222.089) |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
356.426 |
374.261 |
(13.017) |
|
|
|
|
|
|
|
|
|
Less |
TAX |
216.267 |
53.751 |
35.048 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
140.159 |
320.510 |
(48.065) |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
2.753 |
(317.757) |
(269.692) |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
142.912 |
2.753 |
(317.757) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
F.O.B. Value of Exports |
1.483 |
114.065 |
35.790 |
|
|
TOTAL EARNINGS |
1.483 |
114.065 |
35.790 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
0.28 |
0.63 |
NA |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
8.88 |
23.96 |
-3.70 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.88 |
9.86 |
-0.32 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.03 |
0.07 |
0.00 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.00 |
0.16 |
0.57 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
23.85 |
1.90 |
0.69 |
FINANCIAL ANALYSIS
[all figures are in
Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Share Capital |
2510.131 |
2510.131 |
5077.320 |
|
Reserves & Surplus |
2508.981 |
2835.813 |
8111.340 |
|
Net worth |
5019.112 |
5345.944 |
13188.660 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
2865.000 |
838.568 |
0.000 |
|
Total borrowings |
2865.000 |
838.568 |
0.000 |
|
Debt/Equity ratio |
0.571 |
0.157 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Total Income |
1299.021 |
1337.782 |
1578.397 |
|
|
|
2.984 |
17.986 |
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Total Income |
1299.021 |
1337.782 |
1578.397 |
|
Profit |
(48.065) |
320.510 |
140.159 |
|
|
(3.70)% |
23.96% |
8.88% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
-- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
No |
UNSECURED LOAN
(Rs.
In Millions)
|
Particulars |
As on 31.03.2013 |
As on 31.03.2012 |
|
SHORT TERM
BORROWINGS |
|
|
|
Intercorporate borrowings |
0.000 |
838.568 |
|
|
|
|
|
|
|
|
|
Total |
0.000 |
838.568 |
BUSINESS OVERVIEW:
During the year, the Company recorded a Net Revenue of Rs. 1578.397 millions, an increase of 18% over Rs. 1337.782 millions in the previous year. The Company has incurred a Net Profit after Tax of Rs. 140.159 millions as compared to a Net Profit after Tax of Rs. 320.510 millions for the previous year.
INDEX OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
90160958 |
27/07/1998 |
257,500,000.00 |
ANZ GRINDLAYS BANK LIMITED |
90; M.G.ROAD, FORT, MUMBAI, MAHARASHTRA, INDIA |
- |
|
2 |
90163748 |
27/07/1998 |
257,500,000.00 |
ANZ GRINDLAYS BANK LIMITED |
90; M.G.ROAD, FORT, MUMBAI, MAHARASHTRA, INDIA |
- |
|
3 |
90166403 |
10/10/1995 |
157,500,000.00 |
THE HONGKONG AND SHANGAI BANK CO.LTD. |
52/60 ; GANDHI MARG, FORT, BOMBAY, MAHARASHTRA, INDIA |
- |
|
4 |
90163219 |
15/09/1995 |
80,000,000.00 |
SOCIETE GENERALE MAKER CHAMBER IV |
NARIMAN POINT, FORT, BOMBAY, MAHARASHTRA, INDIA |
- |
FIXED ASSETS
· Plant and equipment
· Furniture and fixtures
· Office equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 61.01 |
|
|
1 |
Rs. 102.70 |
|
Euro |
1 |
Rs. 81.91 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
DPH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
54 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely
sound financial base with the strongest capability for timely payment of interest
and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate
working capital. No caution needed for credit transaction. It has above
average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational
base are regarded healthy. General unfavourable factors will not cause fatal
effect. Satisfactory capability for payment of interest and principal sums |
Fairly
Large |
|
41-55 |
Ba |
Overall operation is considered
normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent.
Repayment of interest and principal sums in default or expected to be in
default upon maturity |
Limited
with full security |
|
<10 |
C |
Absolute credit risk
exists. Caution needed to be exercised |
Credit
not recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.